The complex molecular pharmacology of the dopamine D2 receptor: Implications for pramipexole, ropinirole, and rotigotine

M Ferraiolo, E Hermans - Pharmacology & therapeutics, 2023 - Elsevier
With L-DOPA, dopamine agonists such as pramipexole, ropinirole and rotigotine constitute
key therapeutic options for the management of motor symptoms of Parkinson's disease …
被引用次数：6 相关文章

The complex molecular pharmacology of the dopamine D2 receptor: Implications for pramipexole, ropinirole, and rotigotine.

M Ferraiolo, E Hermans - Pharmacology & Therapeutics, 2023 - europepmc.org
With L-DOPA, dopamine agonists such as pramipexole, ropinirole and rotigotine constitute
key therapeutic options for the management of motor symptoms of Parkinson's disease …

The complex molecular pharmacology of the dopamine D receptor: Implications for pramipexole, ropinirole, and rotigotine.

M Ferraiolo, E Hermans - Pharmacology & therapeutics, 2023 - dial.uclouvain.be
With L-DOPA, dopamine agonists such as pramipexole, ropinirole and rotigotine constitute
key therapeutic options for the management of motor symptoms of Parkinson's disease …

The complex molecular pharmacology of the dopamine D2 receptor: Implications for pramipexole, ropinirole, and rotigotine

M Ferraiolo, E Hermans - Pharmacology & therapeutics, 2023 - pubmed.ncbi.nlm.nih.gov
With L-DOPA, dopamine agonists such as pramipexole, ropinirole and rotigotine constitute
key therapeutic options for the management of motor symptoms of Parkinson's disease …